Literature DB >> 25378133

Off-target assessment of CRISPR-Cas9 guiding RNAs in human iPS and mouse ES cells.

E-Pien Tan1, Yilong Li, Martin Del Castillo Velasco-Herrera, Kosuke Yusa, Allan Bradley.   

Abstract

The CRISPR-Cas9 system consists of a site-specific, targetable DNA nuclease that holds great potential in gene editing and genome-wide screening applications. To apply the CRISPR-Cas9 system to these assays successfully, the rate at which Cas9 induces DNA breaks at undesired loci must be understood. We characterized the rate of Cas9 off-target activity in typical Cas9 experiments in two human and one mouse cell lines. We analyzed the Cas9 cutting activity of 12 gRNAs in both their targeted sites and ∼90 predicted off-target sites per gRNA. In a Cas9-based knockout experiment, gRNAs induced detectable Cas9 cutting activity in all on-target sites and in only a few off-target sites genome-wide in human 293FT, human-induced pluripotent stem (hiPS) cells, and mouse embryonic stem (ES) cells. Both the cutting rates and DNA repair patterns were highly correlated between the two human cell lines in both on-target and off-target sites. In clonal Cas9 cutting analysis in mouse ES cells, biallelic Cas9 cutting was observed with low off-target activity. Our results show that off-target activity of Cas9 is low and predictable by the degree of sequence identity between the gRNA and a potential off-target site. Off-target Cas9 activity can be minimized by selecting gRNAs with few off-target sites of near complementarity.
© 2014 The Authors. Genesis Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  genetics; mammal; organism; process

Mesh:

Substances:

Year:  2014        PMID: 25378133     DOI: 10.1002/dvg.22835

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  26 in total

1.  CRISPR: A path through the thicket.

Authors:  Debra J H Mathews; Sarah Chan; Peter J Donovan; Thomas Douglas; Christopher Gyngell; John Harris; Alan Regenberg; Robin Lovell-Badge
Journal:  Nature       Date:  2015-11-12       Impact factor: 49.962

Review 2.  A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research.

Authors:  Joseph M Miano; Qiuyu Martin Zhu; Charles J Lowenstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-21       Impact factor: 8.311

Review 3.  Modeling Psychiatric Disorder Biology with Stem Cells.

Authors:  Debamitra Das; Kyra Feuer; Marah Wahbeh; Dimitrios Avramopoulos
Journal:  Curr Psychiatry Rep       Date:  2020-04-21       Impact factor: 5.285

Review 4.  Therapeutic genome editing: prospects and challenges.

Authors:  David Benjamin Turitz Cox; Randall Jeffrey Platt; Feng Zhang
Journal:  Nat Med       Date:  2015-02       Impact factor: 53.440

5.  Nuclear receptor corepressors Ncor1 and Ncor2 (Smrt) are required for retinoic acid-dependent repression of Fgf8 during somitogenesis.

Authors:  Sandeep Kumar; Thomas J Cunningham; Gregg Duester
Journal:  Dev Biol       Date:  2016-08-06       Impact factor: 3.582

6.  Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements.

Authors:  Michael Kosicki; Kärt Tomberg; Allan Bradley
Journal:  Nat Biotechnol       Date:  2018-07-16       Impact factor: 54.908

Review 7.  Genome engineering tools for building cellular models of disease.

Authors:  Jennie Lin; Kiran Musunuru
Journal:  FEBS J       Date:  2016-06-22       Impact factor: 5.542

Review 8.  Liver-targeted gene therapy: Approaches and challenges.

Authors:  Rajagopal N Aravalli; John D Belcher; Clifford J Steer
Journal:  Liver Transpl       Date:  2015-06       Impact factor: 6.112

9.  A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.

Authors:  Zengrong Zhu; Nipun Verma; Federico González; Zhong-Dong Shi; Danwei Huangfu
Journal:  Stem Cell Reports       Date:  2015-05-28       Impact factor: 7.765

Review 10.  Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases.

Authors:  Kentaro Ishida; Peter Gee; Akitsu Hotta
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.